Literature DB >> 8529317

Variability in leukocyte subset measurements among five laboratories in Vancouver.

K Mandigo1, J M Raboud, L Haley, J S Montaner.   

Abstract

Cell counts and percentages of CD4 are widely used in the prognostic and clinical management of HIV-infected patients, and as surrogate outcomes in clinical trials involving HIV-infected individuals. Considerable variability in CD4 counts has been documented due to physiologic and methodologic factors. While studies of variability of CD4 counts among American and French laboratories have been reported in the literature, no published data are available for Canadian laboratories. This paper describes the results of a study to determine the variability of leukocyte subsets among 5 laboratories in Vancouver, British Columbia. Samples were collected in a prospective fashion from 52 HIV-negative patients from July 1991 to November 1993. Coefficients of variation (CV) were calculated for leukocyte subset percentages and absolute cell counts among laboratories. Our results demonstrate that the variability in leukocyte subsets among 5 Vancouver laboratories was lower than or comparable with published findings. The variability remained stable over the time period of the study, although 4 of the 5 laboratories participated in quality assurance programs. This suggests a plateau in the impact of this program. Since the variability among laboratories is less than the variability attributable to physiologic factors, further research efforts to reduce this variability should focus on physiologic sources.

Entities:  

Mesh:

Year:  1995        PMID: 8529317

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  3 in total

1.  The Italian quality control study for evaluation of CD4 cells in centres involved in the treatment of HIV-1 patients. Italian CD4 Quality Control Group.

Authors:  F Pandolfi; C Alario; E Girardi; L Rava; G Ippolito; A Kunkl; F Aiuti
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

Review 2.  A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humans.

Authors:  Ellen T Chang; Hans-Olov Adami; Paolo Boffetta; H James Wedner; Jack S Mandel
Journal:  Crit Rev Toxicol       Date:  2016-01-13       Impact factor: 5.635

3.  Normal Range of CD4 Cell Counts and Temporal Changes in Two HIVNegative Malawian Populations.

Authors:  A C Crampin; F D Mwaungulu; L R Ambrose; H Longwe; N French
Journal:  Open AIDS J       Date:  2011-08-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.